Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Shares")
-
Shares outstanding
-
60,842,660
-
Total 13F shares
-
58,042,121
-
Share change
-
+1,876,442
-
Total reported value
-
$1,051,734,567
-
Put/Call ratio
-
42%
-
Price per share
-
$18.12
-
Number of holders
-
141
-
Value change
-
+$10,370,393
-
Number of buys
-
89
-
Number of sells
-
73
Institutional Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (the "Shares") (PLRX) as of Q2 2023
As of 30 Jun 2023,
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (the "Shares") (PLRX) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,042,121 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, Deep Track Capital, LP, Laurion Capital Management LP, CHI Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Redmile Group, LLC, TRV GP IV, LLC, and First Light Asset Management, LLC.
This page lists
141
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.